Related Experiment Video
Updated: Feb 7, 2026

03:37
Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
Published on: June 6, 2025
471
[Myasthenia gravis in dentistry].
Nederlands Tijdschrift Voor Tandheelkunde
|July 18, 2018
Summary
Patients with myasthenia gravis (MG) require careful dental treatment planning to prevent myasthenic crises. Consultation with neurologists and preferred local anesthesia are key strategies for safe and effective invasive dental procedures.
Area of Science:
- Neurology
- Dentistry
- Anesthesiology
Background:
- Myasthenia gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
- Myasthenic crisis, a life-threatening complication of MG, can be precipitated by various stressors including dental procedures.
- Invasive dental treatment necessitates a proactive policy to mitigate crisis risk in MG patients.
Purpose of the Study:
- To outline a policy for managing invasive dental treatment in patients with myasthenia gravis.
- To emphasize the importance of pre-procedural consultation and appropriate anesthetic choices.
Main Methods:
- Review of existing literature and clinical guidelines for dental management of MG patients.
- Emphasis on neurologist consultation for medication optimization and preventive strategies.
- Discussion of anesthetic options, favoring local anesthesia over general anesthesia.
Main Results:
- Invasive dental procedures can trigger myasthenic crises in susceptible individuals.
- Consultation with a neurologist is essential for pre-operative planning and potential medication adjustments.
- Amide local analgesics in minimal doses are a viable and preferred anesthetic option compared to narcosis.
Conclusions:
- A multidisciplinary approach involving dentists and neurologists is crucial for safe dental care in MG patients.
- Minimizing stress and optimizing pain management post-procedure are vital to prevent myasthenic crises.
- Careful anesthetic selection and management are paramount for patients with myasthenia gravis undergoing dental interventions.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
3.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.0K
Myasthenia Gravis: Diagnostic Tests
2.6K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.6K

